Drug intelligence / Profile preview

yishenyangsui

Development stage
Preclinical
Lead developer
China Academy of Chinese Medical Sciences
Administration
Oral
01

Overview

Yishenyangsui, also known as the Yishen Yangsui Recipe, is a Traditional Chinese Medicine (TCM) herbal formula developed by researchers at Wang Jing Hospital of the China Academy of Chinese Medical Sciences. It is specifically indicated for the treatment of cervical spondylotic myelopathy (CSM). The formula is based on the TCM theory of "tonifying the kidney and nourishing the marrow" to address the underlying pathology of spinal cord compression and neurological deficit. Clinical research, including long-term follow-up studies, has focused on evaluating its ability to improve clinical outcomes, assess the necessity of surgical intervention, and identify risk factors for reoperation in CSM patients.

Other names
Yishen Yangsui RecipeYishen Yangsui FangYishen Yangsui Decoction
02

Targets

PYCARD (Apoptosis-associated speck-like protein containing a CARD)GSDMD (Gasdermin D)CASP1 (Caspase-1)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on yishenyangsui.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yishenyangsui.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call